N8 Medical, LLC is a clinical-stage medical device company dedicated to revolutionizing medical devices using groundbreaking technology. With a strong focus on ceragenins, a unique class of active compounds, N8 Medical aims to combat and prevent infections caused by biofilm growth on medical devices. These ceragenin-based devices serve as powerful anti-fouling agents, addressing the significant public health and economic burden associated with device-related infections and complications.

N8 Medical firmly believes in the unparalleled efficacy and cost advantages of ceragenins in preventing device-related infections, setting them apart from other medical device companies. By incorporating ceragenins under the CeraShield™ brand, N8 Medical creates a unique and sustainable competitive advantage across various device segments. Ceragenins are synthetic, non-peptide small molecule mimetics that have existed in nature for millions of years.

Unlike traditional agents, they do not induce mutational resistance after serial passaging. For more information on the innovative ceragenin technology and N8 Medical's device pipeline, visit their Technology and Pipeline pages on their website. Contact N8 Medical today to learn more about their groundbreaking ceragenin-based medical devices and the positive impact they can make on patient outcomes